Isolation and characterization of vitreous insulin-like growth factor binding proteins

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 1, 2011, Pages 303-309

  Guidry, Clyde ^a   King, Jeffery L ^a  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LYASE; PLASMA PROTEIN; PROTEIN ANTIBODY; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; IGFBP3 PROTEIN, HUMAN; SOMATOMEDIN BINDING PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL TISSUE; ARTICLE; BIOTINYLATION; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN ISOLATION; PROTEIN PURIFICATION; SWINE; TWO DIMENSIONAL GEL ELECTROPHORESIS; VITREOUS BODY; WESTERN BLOTTING; ANIMAL; CHEMISTRY; ISOLATION AND PURIFICATION;

ANIMALS; BLOTTING, WESTERN; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; MOLECULAR WEIGHT; SWINE; VITREOUS BODY;

EID: 79952238120     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-5920     Document Type: Article

References (34)

1. Frank RN. Diabetic retinopathy. N Engl J Med. 2004;350(1):48-58.
2. Guidry C. The role of Muller cells in fibrocontractive retinal disorders. Prog Retin Eye Res. 2005;24(1):75-86.
3. Sramek SJ, Wallow IH, Stevens TS, et al. Immunostaining of preretinal membranes for actin, fibronectin, and glial fibrillary acidic protein. Ophthalmology. 1989;96(6):835-841.
4. Weller M, Esser P, Heimann K, et al. [Idiopathic proliferative vitreoretinopathy: activation of microglial cells as the deciding factor]. Ophthalmologe. 1992;89(5):387-390.
5. Esser P, Heimann K, Wiedemann P. Macrophages in proliferative vitreoretinopathy and proliferative diabetic retinopathy: differentiation of subpopulations. Br J Ophthalmol. 1993;77(11):731-733.
6. Hosoda Y, Okada M, Matsumura M, et al. Epiretinal membrane of proliferative diabetic retinopathy: an immunohistochemical study. Ophthal Res. 1993;25(5):289-294.
7. Hiscott P, Gray R, Grierson I, et al. Cytokeratin-containing cells in proliferative diabetic retinopathy membranes. Br J Ophthalmol. 1994;78(3):219-222.
8. Mizutani M, Gerhardinger C, Lorenzi M. Muller cell changes in human diabetic retinopathy. Diabetes. 1998;47(3):445-449.
9. Guidry C, King JL, Mason JO 3rd. Fibrocontractive Muller cell phenotypes in proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci. 2009;50(4):1929-1939.
10. Guidry C. Isolation and characterization of porcine Muller cells: myofibroblastic dedifferentiation in culture. Invest Ophthalmol Vis Sci. 1996;37(5):740-52.
11. Guidry C. Tractional force generation by porcine Muller cells: development and differential stimulation by growth factors. Invest Ophthalmol Vis Sci. 1997;38(2):456-468.
12. Guidry C, Bradley KM, King JL. Tractional force generation by human Muller cells: growth factor responsiveness and integrin receptor involvement. Invest Ophthalmol Vis Sci. 2003;44(3): 1355-1363.
13. Guidry C, Feist R, Morris R, et al. Changes in IGF activities in human diabetic vitreous. Diabetes. 2004;53(9):2428-2435.
14. Grant M, Russel B, Fitzgerald C, et al. Insulinlike growth factors in vitreous: studies in control and diabetic subjects with neovascularization. Diabetes. 1986;35:416-420.
15. Meyer-Schwickerath R, Pfeiffer A, Blum WF, et al. Vitreous levels of the insulinlike growth factors I and II, and the insulinlike growth factor binding proteins 2 and 3, increase in neovascular eye disease: studies in nondiabetic and diabetic subjects. J Clin Invest. 1993;92(6):2620-2625.
16. Boulton M, Gregor Z, McLeod D, et al. Intravitreal growth factors in proliferative diabetic retinopathy: correlation with neovascular activity and glycaemic management. Br J Ophthalmology. 1997; 81(3):228-233.
17. Burgos R, Mateo C, Canton A, et al. Vitreous levels of IGF-I, IGF binding protein 1, and IGF binding protein 3 in proliferative diabetic retinopathy: a case-control study. Diabetes Care. 2000; 23(1):80-83.
18. Spranger J, Buhnen J, Jansen V, et al. Systemic levels contribute significantly to increased intraocular IGF- I, IGF-II and IGF-BP3 [correction of IFG-BP3] in proliferative diabetic retinopathy. Horm Metab Res. 2000;32(5):196-200.
19. Inokuchi N, Ikeda T, Imamura Y, et al. Vitreous levels of insulinlike growth factor-I in patients with proliferative diabetic retinopathy. Curr Eye Res. 2001;23(5):368-371.
20. Spranger J, Mohlig M, Osterhoff M, et al. Retinal photocoagulation does not influence intraocular levels of IGF- I, IGF-II and IGF-BP3 in proliferative diabetic retinopathy-evidence for combined treatment of PDR with somatostatin analogues and retinal photocoagulation? Horm Metab Res. 2001;33(5):312-316.
21. Hardwick C, Feist R, Morris R, et al. Tractional force generation by porcine Muller cells: stimulation by growth factors in human vitreous. Invest Ophthalmol Vis Sci. 1997;38(10):2053-2063.
22. Conover CA. Regulation and physiological role of insulinlike growth factor binding proteins. Endocrine J. 1996;43:p. S43-S48.
23. Clemmons DR. Role of insulinlike growth factor binding proteins in controlling IGF actions. Mol Cell Endocrinol. 1998;140(1/2): 19-24.
24. Ferry RJ, Katz LEL, Grimberg A, et al. Cellular actions of insulinlike growth factor binding proteins. Horm Metab Res. 1998;31:192-202.
25. Baxter RC. Insulinlike growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities. Am J Physiol Endocrinol Metab. 2000;278(6):E967-E976.
26. Firth SM, Baxter RC. Cellular actions of the insulinlike growth factor binding proteins. Endocr Rev. 2002;23(6):824-854.
27. Duan C, Xu Q. Roles of insulinlike growth factor (IGF) binding proteins in regulating IGF actions. Gen Comp Endocrinol. 2005; 142(12):44-52.
28. King JL, Guidry C. Insulinlike growth factor binding proteins modulate Muller cell responses to insulinlike growth factors. Invest Ophthalmol Vis Sci. 2004;45(12):4535-4542.
29. Schoen TJ, Waldbillig RJ, Searcy G, et al. Identification and partial characterization of a proteinase specific for insulinlike growth factor binding protein-3 in aqueous and vitreous humors. Curr Eye Res. 1995;14(2):127-135.
30. King JL, Guidry C. Muller cell production of insulinlike growth factor binding proteins in vitro: modulation with phenotype and growth factor stimulation. Invest Ophthalmol Vis Sci. 2004; 45(12):4535-4542.
31. Laemmli U. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;74:856-875.
32. Firth SM, Baxter RC. Characterisation of recombinant glycosylation variants of insulinlike growth factor binding protein-3. J Endocrinol. 1999;160(3):379-387.
33. Ahlsen M, Carlsson-Skwirut C, Jonsson AP, et al. A 30-kDa fragment of insulinlike growth factor (IGF) binding protein-3 in human pregnancy serum with strongly reduced IGF-I binding. Cell Mol Life Sci. 2007;64(14):1870-1880.
34. Yan X, Payet LD, Baxter RC, et al. Activity of human pregnancy insulinlike growth factor binding protein-3: determination by reconstituting recombinant complexes. Endocrinology. 2009; 150(11):4968-4976.